(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202406 | 202306 | % Var | 202406 | 202306 | % Var | 202403 | 202303 | % Var | |
| Sales | 26.53 | 40.62 | -34.69 | 26.53 | 40.62 | -34.69 | 144.72 | 131.29 | 10.23 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.69 | 3.76 | -28.46 |
| PBIDT | 2.00 | 3.10 | -35.48 | 2.00 | 3.10 | -35.48 | 4.98 | 4.06 | 22.66 |
| Interest | 0.03 | 0.01 | 200.00 | 0.03 | 0.01 | 200.00 | 0.14 | 0.07 | 100.00 |
| PBDT | 1.97 | 3.09 | -36.25 | 1.97 | 3.09 | -36.25 | 4.84 | 3.99 | 21.30 |
| Depreciation | 0.41 | 0.52 | -21.15 | 0.41 | 0.52 | -21.15 | 2.09 | 2.80 | -25.36 |
| PBT | 1.56 | 2.57 | -39.30 | 1.56 | 2.57 | -39.30 | 2.75 | 1.19 | 131.09 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.72 | 0.40 | 80.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.09 | -77.78 |
| PAT | 1.56 | 2.57 | -39.30 | 1.56 | 2.57 | -39.30 | 2.03 | 0.79 | 156.96 |
| Equity | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 |
| PBIDTM(%) | 7.54 | 7.63 | -1.22 | 7.54 | 7.63 | -1.22 | 3.44 | 3.09 | 11.28 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1817.20 |
| Dr. Reddys Lab | 1273.00 |
| Cipla | 1324.40 |
| Zydus Lifesciences | 910.90 |
| Lupin | 2345.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: